What Researchers Did
Researchers prospectively investigated the effect of hyperbaric oxygen treatment (HBOT) on pain in 16 gynaecological cancer patients experiencing late radiation tissue injury (LRTI) after pelvic radiation therapy.
What They Found
Hyperbaric oxygen treatment (HBOT) showed an insignificant effect on pain, daily function, analgesic consumption, and MRI-related tissue injury in the 16 patients studied. However, 50% of the patients still reported some or good subjective effect from the treatment.
What This Means for Canadian Patients
Canadian gynaecological cancer patients experiencing late radiation tissue injury (LRTI) may find that hyperbaric oxygen therapy (HBOT) does not significantly reduce their pain or improve daily function. Patients should discuss all available treatment options with their healthcare providers, as more research is needed to determine optimal patient selection for HBOT.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Norway.
Study Limitations
A significant limitation of this study is its small sample size of 16 patients, which prevents definitive conclusions about the efficacy of HBOT for gynaecological patients with late radiation tissue injury.